Urgent

Anti-arrhythmics in the ICU

Rhythm drugs · Critical Care / ICU
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

ICU staples: adenosine (diagnostic/therapeutic for regular narrow SVT), amiodarone (broad-spectrum, least negatively inotropic — first-line in the compromised), beta-blockers/verapamil (rate control — never verapamil in broad-complex), digoxin (rate control in heart failure), magnesium (torsades, digoxin toxicity, refractory arrhythmia), lidocaine (VT alternative, ischaemic).

Red flags

  • Verapamil in an undiagnosed broad-complex tachycardia can be fatal — treat as VT
  • Digoxin toxicity is pro-arrhythmic: bidirectional VT, blocks — check level and K⁺

Management

  • Unstable + tachyarrhythmia = electricity, not pharmacology (synchronised DC)
  • Before drugs: fix K⁺ >4.0–4.5, Mg²⁺ >1.0, oxygenation, and remove the pro-arrhythmic causes (catecholamines, acidosis, central-line tip in RA)
  • All anti-arrhythmics are also PRO-arrhythmic and negatively inotropic to a degree — one drug at a time; combining raises block/torsades risk
  • New-onset AF in the septic ICU patient: rate/rhythm often returns with treating the sepsis and the K⁺/Mg²⁺ — amiodarone if compromised
  • Watch QT with amiodarone/haloperidol combinations; daily ECG on infusions

Drugs & doses

Adenosine 6→12→18 mg rapid IV push (large vein, warn the patient)
Amiodarone 300 mg over 20–60 min then 900 mg/24 h — central line for infusions
Magnesium 2 g IV over 10–15 min (torsades: give even if level normal)
Metoprolol 2.5–5 mg IV titrated / esmolol infusion
Digoxin load 500 mcg IV repeated — rate control with hypotension/HF

Electricity for the unstable; electrolytes before drugs; one anti-arrhythmic at a time.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.